These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 9300187

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Chlamydia trachomatis testing in the second British national survey of sexual attitudes and lifestyles: respondent uptake and treatment outcomes.
    McCadden A, Fenton KA, McManus S, Mercer CH, Erens B, Carder C, Ridgway G, Macdowall W, Nanchahal K, Byron CL, Copas A, Wellings K, Johnson AM.
    Sex Transm Dis; 2005 Jun; 32(6):387-94. PubMed ID: 15912087
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Potentials of screening for Chlamydia trachomatis in Hungary: cost-benefit analysis].
    Nyári T, Mészáros G, Deák J, Nagy E, Kovács L.
    Orv Hetil; 2000 Jul 02; 141(27):1511-6. PubMed ID: 10943109
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Screening women for chlamydia trachomatis in family planning clinics: the cost-effectiveness of DNA amplification assays.
    Howell MR, Quinn TC, Brathwaite W, Gaydos CA.
    Sex Transm Dis; 1998 Feb 02; 25(2):108-17. PubMed ID: 9518379
    [Abstract] [Full Text] [Related]

  • 13. Screening for Chlamydia trachomatis in asymptomatic women in Hungary. An epidemiological and cost-effectiveness analysis.
    Nyári T, Nyári C, Woodward M, Mészáros G, Deák J, Nagy E, Kovács L.
    Acta Obstet Gynecol Scand; 2001 Apr 02; 80(4):300-6. PubMed ID: 11264602
    [Abstract] [Full Text] [Related]

  • 14. Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens.
    van Valkengoed IG, Postma MJ, Morré SA, van den Brule AJ, Meijer CJ, Bouter LM, Boeke AJ.
    Sex Transm Infect; 2001 Aug 02; 77(4):276-82. PubMed ID: 11463928
    [Abstract] [Full Text] [Related]

  • 15. Screening for Chlamydia trachomatis: a systematic review of the economic evaluations and modelling.
    Roberts TE, Robinson S, Barton P, Bryan S, Low N, Chlamydia Screening Studies (ClaSS) Group.
    Sex Transm Infect; 2006 Jun 02; 82(3):193-200; discussion 201. PubMed ID: 16731666
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Should asymptomatic men be included in chlamydia screening programs? Cost-effectiveness of chlamydia screening among male and female entrants to a national job training program.
    Blake DR, Quinn TC, Gaydos CA.
    Sex Transm Dis; 2008 Jan 02; 35(1):91-101. PubMed ID: 18217229
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Incidence and repeat infection rates of Chlamydia trachomatis among male and female patients in an STD clinic: implications for screening and rescreening.
    Rietmeijer CA, Van Bemmelen R, Judson FN, Douglas JM.
    Sex Transm Dis; 2002 Feb 02; 29(2):65-72. PubMed ID: 11818890
    [Abstract] [Full Text] [Related]

  • 20. Screening for Chlamydia trachomatis in adolescent males: a cost-based decision analysis.
    Randolph AG, Washington AE.
    Am J Public Health; 1990 May 02; 80(5):545-50. PubMed ID: 2109544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.